TMCnet News
BUYINS.NET: RDEA, AXN, DXD, DFZ, SONO, SPNS Are Seasonally Ripe To Go Down In the Next Five Weeks(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ARDEA BIOSCIENCES INC (NASDAQ:RDEA), AOXING PHARMACEUTICAL CO INC (AMEX:AXN), PROSHARES ULTRASHORT DOW30 (AMEX:DXD), BARRY (NASDAQ:DFZ), SONOSITE INC (NASDAQ:SONO), SAPIENS INTERNATIONAL CORP (NASDAQ:SPNS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date RDEA ARDEA BIOSCIENCES INC -7.48% 81.82% (9 of 11) Wednesday, October 26th 2011 AXN AOXING PHARMACEUTICAL CO INC -23.28% 87.50% (7 of 8) Wednesday, October 12th 2011 DXD PROSHARES ULTRASHORT DOW30 -2.41% 100.00% (5 of 5) Friday, October 14th 2011 DFZ BARRY -3.17% 81.82% (9 of 11) Wednesday, October 12th 2011 SONO SONOSITE INC -1.88% 90.91% (10 of 11) Monday, October 10th 2011 SPNS SAPIENS INTERNATIONAL CORP -7.08% 100.00% (10 of 10) Tuesday, October 11th 2011 ARDEA BIOSCIENCES INC (NASDAQ:RDEA) - Ardea Biosciences, Inc., a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), and cancer in the United States. The companys products include RDEA594, a Phase IIb clinical trial product for the treatment of gout; RDEA684, a preclinical trial product for the treatment of gout with hyperuricemia; RDEA806, a non-nucleoside reverse transcriptase inhibitor, which completed Phase II clinical trial for the treatment of patients with HIV; and RDEA427, which is in first-in-human micro-dose pharmacokinetic study for the treatment of HIV infection. It is evaluating RDEA119, an inhibitor of Mitogen-activated ERK kinase (MEK), which is in Phase I/II study in combination with sorafenib and as a single agent in a Phase I study, both in advanced cancer patients. The company has a license agreement with Bayer to develop and commercialize MEK inhibitors for various indications. Ardea Biosciences, Inc. is based in San Diego, California. AOXING PHARMACEUTICAL CO INC (AMEX:AXN) - Aoxing Pharmaceutical Company, Inc., a specialty pharmaceutical company, through its subsidiary, Hebei Aoxing Pharmaceutical Co., Inc., engages in the research, development, manufacture, and distribution of various narcotics, neurological disorders, and pain-management products in the Peoples Republic of China. Its product line includes prescription and over-the-counter pharmaceutical products. The company offers its products in various formulations, such as injection, tablets, capsules, oral solution, and powders. Its approved products include paracetamol and caffeine tablets, Zhongtong'an capsules, Naloxone Hydrochloride injection, Shuanghuanlian capsules, Ligustrazine Phosphate injection, and Xiaopiling granules; and narcotic pipeline products comprise Tilidine HCl tablets, oxycodone and paracetamol, Tilidine and Naloxone, compound codeine phosphate oral solution, Pholcodine oral syrup, and Buprenorphine and Naloxone sublingual tablets. Aoxing Pharmaceutical Company sells its products primarily to hospitals, clinics, pharmacies, and retailers. The company has strategic alliance partnerships with QRx Pharma Ltd.; American Oriental Bioengineering, Inc.; and Phoenix Pharmalabs, Inc. The company was formerly known as China Aoxing Pharmaceutical Co., Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. The company was founded in 1655 and is based in Jersey City, New Jersey. PROSHARES ULTRASHORT DOW30 (AMEX:DXD) - ULTRASHORT DOW30 PRO BARRY (NASDAQ:DFZ) - R.G. Barry Corporation, together with its subsidiaries, engages in designing, sourcing, marketing, and distributing accessory footwear products in North America. The company offers indoor/outdoor casual footwear under the Terrasoles brand, and canvas/active fashion footwear products under the Superga brand. Its products include slippers, sandals, hybrid and active fashion footwear, and slipper socks. The company also offers its products under the Angel Treads, Dearfoams, DF Women, DF Men, Dearfoams DF, DFSport, EZfeet, Dearfoams NV, Snug Treds, Sol, Terrasoles, Utopia, Soluna, Levis, and Nautica brand names. It markets its products through traditional, promotional, and national chain department stores; mass merchants; discount stores; warehouse clubs; off-price retailers; specialty stores; independent retailers; catalogs; and Internet sites. R.G. Barry Corporation was founded in 1945 and is headquartered in Pickerington, Ohio. SONOSITE INC (NASDAQ:SONO) - SonoSite, Inc. develops, manufactures, and distributes hand-carried ultrasound systems for use across medical specialties and in a range of treatment settings. Its products include NanoMaxx Ultrasound Tool, which supports a range of examinations and procedures, including thoracic assessment for hemothorax, hydrothorax and pneumothorax, vascular access, needle aspirations, and injections, as well as abdominal, cardiac, nerve, obstetrics/gynecology, musculoskeletal, small parts, and vascular scanning; The M-Turbo system, which is used in clinical and procedural guidance applications at the point-of-care, such as abdominal, nerve, vascular, cardiac, venous access, small part, and superficial imaging; S Series ultrasound tools; MicroMaxx System used in anesthesia, cardiology, critical and acute care, emergency medicine, obstetrics/gynecology, preventive cardiology, radiology, surgery, and vascular applications; and non-invasive hemodynamic parameters for tracking and evaluating cardiovascular health. The company also offers accessories for its products that include mobile docking stations, multiple transducer connections, image transfer and management software, printers, video recorders, auxiliary monitors, storage devices, carrying cases, and disposable supplies. In addition, it develops programs in ultrasound education. The company sells its products directly, as well as through independent third-party distributors and strategic alliances in the United States, Australia, Canada, France, Germany, India, Italy, Japan, Spain, the United Kingdom, Africa, Asia, China, the Middle East, and Latin America. SonoSite, Inc. was founded in 1986 and is headquartered in Bothell, Washington. SAPIENS INTERNATIONAL CORP (NASDAQ:SPNS) - Sapiens International Corporation N.V. provides information technology (IT) solutions for the insurance industry. It primarily offers Sapiens INSIGHT, a suite of modular business software solutions for the property and casualty, life insurance, and pension markets. The company provides solutions for property and casualty, policy administration, billing and collections, claim handling, reinsurance, life and pensions, and underwriting, as well as for life and pension insurance companies seeking ways to reduce the cost of maintaining closed books of business. Its solutions are built on Sapiens eMerge, which is an enterprise-scale transaction engine that facilitates business process integrity, application scalability, and performance. The company also provides IT services in various areas, including project management, application development/enhancements, application platform porting services, and general technical assistance. In addition, it serves multi-year outsourcing contracts involving mission-critical systems. The company sells its products and services to insurance companies, banks, government, and manufacturing companies through direct sales force, relationships with system integrators, and distributors, as well as through marketing alliances with IT solutions providers. It primarily offers its products and services in North America, Europe, Israel, and Japan. Sapiens International Corporation N.V. was founded in 1982 and is headquartered in Rehovot, Israel. SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements". RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO. INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports. Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks. Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups. Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks. GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time. About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades. SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin. All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind. Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC. Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 [email protected] SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). (c) 2011 M2 COMMUNICATIONS |